Spark BioPharma

Raised $21.4M in a Growth round, announced 11 May 2026.

Total raised
$21.4M

Latest round GrowthCountry South KoreaSector Health

Round

$21.4MGrowth, 11 May 2026

Pre-IPO round from nine institutions to fund SBP-401 Phase 2a data ahead of a KOSDAQ listing.

Amount
$21.4M
Stage
Growth
Announced
11 May 2026
Lead
Korea Development Bank
Other investors
IBK Industrial Bank, Shinhan Capital, SJ Partners, Mford Equity, Openwater Investment, Plexus Partners, AOA Capital Partners
Use of funds
Pre-IPO round from nine institutions to fund SBP-401 Phase 2a data ahead of a KOSDAQ listing.
Checked
Amount and date matched across 2 press sources
Sources
Spark BioPharma closes ₩31.5B ($22.8M) pre-IPO round news.bizwatch.co.kr
Spark BioPharma closes ₩31.5B ($22.8M) pre-IPO round en.wowtale.net
Newsletter Startup rounds, in your inbox.

Free. Unsubscribe anytime.

Company

Develops new drugs, lead candidate SBP-401 in Phase 2a trials

Based in
South Korea
Sector
Health

Questions

How much has Spark BioPharma raised?

Spark BioPharma raised $21.4M in a Growth round, announced on 11 May 2026.

Who invested in Spark BioPharma?

Korea Development Bank led. Investors include Korea Development Bank, IBK Industrial Bank, Shinhan Capital, SJ Partners, Mford Equity and Openwater Investment.